# AutoReviewer Report

> Calibration warning: this run reproduces the Nature pipeline structure, but substitutes
> DeepSeek V4 Flash for the paper's validated o4-mini model. Its scores are not human-calibrated.

- Paper: B152.txt
- Model: deepseek-v4-flash
- Final decision: **Reject**
- Overall: **6/10**
- Confidence: **4/5**
- Independent decisions: {'Accept': 3, 'Reject': 2}
- Estimated API cost: **$0.021159**

## Final Meta-review

The paper introduces AReUReDi (Annealed Rectified Updates for Refining Discrete Flows), a discrete optimization algorithm for multi-objective biomolecular sequence design. Building on Rectified Discrete Flows (ReDi), it combines Tchebycheff scalarization, locally balanced proposals, annealed guidance strength, and Metropolis-Hastings updates to bias sampling toward Pareto-optimal states. The authors provide theoretical guarantees of convergence to the Pareto front with full coverage. The method is validated on peptide and SMILES sequence design, optimizing up to five therapeutic properties (affinity, solubility, hemolysis, half-life, non-fouling) across multiple protein targets, and shows improvements over evolutionary algorithms (NSGA-III, SMS-EMOA, SPEA2, MOPSO) and a masked discrete diffusion baseline (PepTune). Two new rectified base models (PepReDi and SMILESReDi) are also introduced.

### Scores

| Dimension | Final | Five-review mean | SD | Range |
|---|---:|---:|---:|---:|
| Originality | 3 | 3.000 | 0.000 | 3-3 |
| Quality | 3 | 3.000 | 0.000 | 3-3 |
| Clarity | 3 | 3.000 | 0.000 | 3-3 |
| Significance | 3 | 3.000 | 0.000 | 3-3 |
| Soundness | 3 | 3.000 | 0.000 | 3-3 |
| Presentation | 3 | 3.000 | 0.000 | 3-3 |
| Contribution | 3 | 3.000 | 0.000 | 3-3 |
| Overall | 6 | 5.600 | 0.490 | 5-6 |
| Confidence | 4 | 4.000 | 0.000 | 4-4 |

### Strengths

- Addresses an important and practically relevant problem: multi-objective optimization for therapeutic biomolecular design
- Novel combination of rectified discrete flows with MCMC-based multi-objective guidance, integrating Tchebycheff scalarization and annealed locally balanced proposals
- Comprehensive experimental evaluation across multiple protein targets, sequence lengths, and up to five objectives, covering both wild-type peptides and SMILES
- Theoretical guarantees (invariance, convergence to Pareto front, representability, coverage) are stated and proved
- Well-designed ablation studies demonstrate the value of rectification and annealed guidance
- Introduces two new base models (PepReDi and SMILESReDi) with improved validity and diversity
- Code and models are publicly available

### Weaknesses

- The monotonicity constraint used in all main experiments breaks the theoretical convergence guarantees, creating a significant theory-practice gap that is not rigorously analyzed
- Theoretical novelty is limited: locally balanced proposals, Metropolis-Hastings, and Tchebycheff scalarization are standard techniques; the contribution is primarily in the combination
- No quantitative Pareto front metrics (e.g., hypervolume, IGD) are reported; the paper relies on average property scores rather than demonstrating actual Pareto optimality or coverage
- The half-life predictor is trained on only 105 data points, raising concerns about the reliability of half-life optimization results
- Runtime is substantially higher than baselines (55-195s vs 2-37s per binder), limiting practical scalability and creating an unfair comparison when baselines are given much shorter budgets
- All evaluation is in silico using predicted property scores; no experimental (wet-lab) validation of designed peptides is provided
- The claim of 'full coverage of the Pareto front' is only theoretically justified in the limit of infinite sampling and without the monotonicity constraint; practical coverage is not demonstrated
- Affinity scores are sometimes lower than evolutionary baselines (e.g., 5.7130 vs 7.3240 for SPEA2 on 1B8Q), indicating trade-offs that are not fully discussed

### Questions

- The monotonicity constraint used in all experiments breaks the detailed balance condition. Can you provide a rigorous analysis of what theoretical guarantees still hold, or characterize conditions under which convergence to the Pareto front might fail?
- How are the weights ω chosen in practice? Is there sensitivity analysis, and how does weight selection affect the trade-offs and coverage of the Pareto front?
- Can you provide quantitative Pareto front metrics (e.g., hypervolume, IGD) or visualizations to demonstrate that the method actually achieves Pareto optimality and coverage rather than just high average scores?
- How reliable are the half-life predictions given the 105-sample training set? Were any uncertainty estimates or validation on held-out experimental data performed?
- Would the results change if evolutionary baselines were given matched computational budgets? Can you provide results with comparable runtime?
- How does the method scale to more than 5 objectives or longer sequences (e.g., >1000 tokens)? What are the computational bottlenecks?
- For the SMILES experiments, why were PepTune's property scores not reported? A fair comparison would require quantitative evaluation of both methods under the same protocol.
- How sensitive are the results to the choice of balancing function (Barker vs square-root)? Is there an empirical comparison?

### Limitations

- The monotonicity constraint is a heuristic that breaks the theoretical convergence guarantees and may limit exploration of the state space
- The reliance on predicted scores from models with modest accuracy (e.g., affinity Spearman 0.64, hemolysis F1=0.58) could lead to suboptimal designs in practice
- The computational cost is significantly higher than baseline methods, which may limit applicability to large-scale screening
- No experimental validation (in vitro or in vivo) was performed, so the practical utility of the designed peptides remains unverified
- Potential negative societal impact: the method could be used to design harmful biological agents; the authors do not discuss this risk or mitigation strategies
- The paper does not address potential biases in the training data for property predictors, which could lead to systematically flawed optimization

### Ethics

Ethical concerns flagged: **False**

## Usage and Cost

- Requests: 6
- Prompt tokens: 138,803
- Cache-hit prompt tokens: 8,960
- Cache-miss prompt tokens: 129,843
- Completion tokens: 10,556
- Reasoning tokens reported: 0
- Total tokens: 149,359
- Estimated total: $0.02115879

Full individual reviews and raw JSON responses are in `review_bundle.json`.
